On 25-26 January 2024, the biannual VANGUARD General Assembly took place in Innsbruck-Igls, Austria. Seventeen representatives from the consortium’s eight project partners gathered for a two-day event focused on project updates, planning, and discussions. The meeting was kindly hosted by
On 14th November 2024, the University of Geneva (UNIGE) hosted Diabetes Days 2024, an event dedicated to raising awareness about diabetes and highlighting advancements in research. Organised by the Faculty of Medicine and the Department of Cell Physiology and Metabolism,
On Monday, 16th December 2024, VANGUARD partners from the Transplantation Department at Lyon Claude Bernard University and Edouard Herriot University Hospital participated in the 6th Lyon Immunopathology Federation (LIFe) seminar held in Lyon, France. The event brought together physicians, immunology
Today, on World Diabetes Day, we emphasise the importance of open communication with patients and advocacy groups. Each November, VANGUARD partners connect, listen, and share progress with our community. This year, our partners are participating in three special patient-oriented events
A new VANGUARD article titled “The bio-artificial pancreas to treat type 1 diabetes: Perspectives from healthcare professionals in the Netherlands” has been published in the Journal of Clinical & Translational Endocrinology. This publication is openly accessible online here. In their
On 27th September, VANGUARD partners from the University of Eastern Piedmont (UPO) took part in the European Researchers’ Night 2024, the largest science outreach event in Europe. Held at the Department of Science and Technological Innovation in Alexandria, the XIX
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 874700